11.05.2011 • Product

Accelrys' Materials Studio: A Comprehensive Materials Modeling and Simulation Application

Photo

Discover how to streamline your innovation cycle and drive better, faster results with Materials Studio - a comprehensive materials modeling and simulation application designed for scientists in chemicals and materials R&D, as well as pharmaceutical development.

With Materials Studio, you can improve product and process quality by rationalizing behavior and designing improvements while reducing costs through "in-silico screening" that focuses experimentation on productive pathways.

Materials Studio reduces the time needed to solve complex calculations with:

  • Industry-leading graphical user environments
  • State-of-the-art simulation technology from quantum to atomistic to mesoscale
  • Powerful statistical tools for structure-property relationships

Materials Studio provides a comprehensive set of scientific capabilities for modeling crystal structure and crystallization processes; for property prediction for molecules, polymers, catalysts, and other materials; and for the development of structure-activity relationships.

With Materials Studio you can:

  • Reduce the number of costly and often lengthy experiments needed to bring a product to market
  • Minimize the time needed to set up and solve complex calculations
  • Make well-informed decisions in research on a wide range of systems including catalysts, polymers, specialty chemicals, advanced materials and drug development

Learn more about Materials Studio:

 

Company

Accelrys Inc. - Corporate Headquarters

10188 Telesis Court, Suite 100
San Diego, CA 92121

Company contact







Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read